Agelasines B, D and antimicrobial extract of a marine sponge Agelas sp. from Tahuna Bay, Sangihe Islands, Indonesia
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
Abstract. Balansa W, Wodi SIM, Rieuwpassa FJ, Ijong FG. 2020. Agelasines B, D and antimicrobial extract of Agelas sp. from Tahuna Bay, Sangihe Islands, Indonesia. Biodiversitas 21: 699-706. The alarming growth of antibiotic-resistant bacteria necessitates the discovery of new antibiotics including those for combating life-threatening ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter sp) and fish pathogenic bacteria. This study aimed to identify antimicrobial compounds from an extract of a marine sponge collected from Enepahembang coral reef, Sangihe Islands, North Sulawesi, Indonesia. The sponge was identified by DNA barcoding as Agelas sp. and its extract was evaluated against three ESKAPE bacteria (S. aureus, K. pneumoniae, and A. baumannii) and three fish pathogenic bacteria (A. hydrophila, Edwardsiella tarda and Vibrio parahaemolyticus), using the standard disk diffusion method. It showed moderate to strong antimicrobial activity against S. aureus (25.3 mm), K. pneumoniae (15.5 mm), A. baumannii (20.2 mm), A. hydrophila (20.5 mm), E. tarda (22.4 mm) and A. salmonicida (21.2 mm). The extract was isolated by chromatographic techniques (column chromatography, flash chromatography, and high-performance liquid chromatography). The structures and relative stereochemistry of the two compounds were elucidated by HRESIMS, 1D and 2D NMR data analysis as well as by comparison with reported values. Unfortunately, limited amount of the pure compounds prevented us from further evaluating their antimicrobial activity against the test bacteria. Nevertheless, the crude extract's strong antimicrobial activity, especially against the test Gram-negative bacteria, suggests the importance of this finding in light of the recent antimicrobial drug scarcity but rapid antimicrobial resistance and the emerging paradigm of antimicrobial drug modification, redirection and/or repurposing for discovering new antibiotics particularly against the life-threatening Gram-negative bacteria.
##plugins.themes.bootstrap3.article.details##
Appenzeller J, Mihci G, Martin MT, Gallard JF, Menou JL, Esnault NB, Hooper JNA, Petek S, Maurel SC, Valentin A, Zaparucha A, AlMourabit A, Debitus C. Agelasines J, K, and L from the Solomon Islands Marine Sponge Agelas cf. mauritiana. J. Nat. Prod. 71 (8): 1451-1454. doi: 10.1021/np800212g
Arai M, Yamano Y, Setiawan A, Kobayashi M. 2014. Identification of the Target Protein of Agelasine D, a Marine Sponge Diterpene Alkaloid, as an Anti-dormant Mycobacterial Substance. Chemibiochem 15(1): 117-123. doi:10.1002/cbic.201300470
Azhari D, Makiseke AM, Tomasoa AM, Lumiu G, Balansa W. 2018. Aktivitas Antibakteri Ekstrak Kasar Spons Agelas clathrodes Terhadap Bakteri Patogenik Ikan Vibrio parahaemolyticus. Jurnal Tindalung 4 (2): 53-56
Bakkestuen AK, Gundersen LL, Petersen D, Utenova BT, Vik A. 2005. Synthesis and antimycobacterial activity of agelasine E and analogs. Org. Biomol. Chem. 3 (6): 1025-1033. doi:10.1039/b417471b
Balansa W, Azhari D, Babo D, Tomasoa AM. 2017. Aktivitas Antibakteri Ekstrak Sponge Perairan Enepahembang Terhadap Bakteri Patogenik Ikan Aeromonas Hydrophila. Jurnal Tindalung 3(1): 1-7. https://doi.org/10.5281/jit.v3i1.93
Balansa W, Mettal U, Wuisan ZG, Plubrukarn A, Frans GI, LiuY, SchaeberleTF. 2019. A new sesquiterpenoid aminoquinone from and Indonesian marine sponge. Marine Drugs 17 (3): 158. doi: 10.3390/md17030158
Bassetti M, Righi E. 2015. New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections. Curr Opin Crit Care. 21(5) : 402-411. doi: 10.1097/MCC.0000000000000235.
Capon RJ, Faulkner DJ. 1994. Antimicrobial Metabolites from a Pacific Sponge, Agelas sp. J. Am. Chem. Soc. 106 (6): 1819-1822. https://doi.org/10.1021/ja00318a045
Canturri AM, Agaba RA, Smani Y. Drug repurposing for the treatment of bacterial and fungal infections. Frontier in microbiology. 2019, 10, 1-12. doi: 10.3389/fmicb.2019.00041
Fahra MA, Brown ED. 2019. Drug repurposing for antimicrobial discovery. Nature microbiology. 4: 565–577. https://doi.org/10.1038/s41564-019-035.
Fair RJ, Tor Y. 2014. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 6: 25–64 doi: 10.4137/PMC.S14459
Founou RC, Founou LL, Essack SY. 2017. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS ONE 12:12. doi: 10.1371/journal.pone. 0189621.
Hoshino T. 1985. Description of two new species in the genus agelas (Demospongia) from Zamami Island, the Ryukyus Japan. Proceedings of the Japanese Society of Systematic Zoology. 30: 1-10, pls I-II.
Jang HJ, Chung YI, Lim C, Chung S, Kim B, Kim ES, Kim SH, Cho YH. 2019. Redirecting an anticancer to antibacterial hit against methicillin resistant Staphylococcus aureus. Frontiers in Microbiology 10: 350 doi: 10.3389/fmicb.2019.00350
Li C, Lewis MR, Gilbert AB, Noel MD, Schoville DH, Aliman GW, Savage PB. 1999. Antimicrobial activities of amine and guanidine functionalized cholic acid derivatives. Antimicrob Agents Chemother.43(6):1347-1349.
McCaffrey EJ, Andean R. 1985. Antimicrobial activity of tropical and sub-tropical sponges. Mar. Biol. 89(1): 1-8 https://doi.org/10.1007/BF00392871
Miller RA, Harbottle H. 2018. Antimicrobial drug resistance in fish pathogens. Microbiology Spectrum 6 : 1. doi:10.1128/microbiolspec.ARBA-0017-2017.
Nakamura H, Wu H, Ohizumi Y, Hirata Y. 1984. Agelasine-A, -B, -C and –D, novel, bicyclic diterpenoids with a 9-methyladeninium unit possessing inhibitory effects on na, K-ATPase from the Okinawa sea, sponge Agelas sp. Tetrahedron Letters 25 (28) : 2989-2992 https://doi.org/10.1016/S0040-4039(01)81345-9
Navidinia M. 2016. The clinical importance of emerging ESKAPE pathogens in nosocomial infections. J. Paramed. Sci. 7 : 2008–4978. doi: 10.22037/jps.v7i3.12584. https://pdfs.semanticscholar.org/a3a4/e464d0ff6b526fcd7da8b813df89350d651a.pdf (accessed Oct, 2019).
Richter MF, Drown BS, Riley AP, Garcia A, Shirai T, Svec RL, Hergenbrother SP. 2017. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545(7654):299-304 doi: 10.1038/nature22308
Rogen H, Charnock C, Burman R, Feith J, Larson R, Lotte L, Gundersen II. 2011. Antimicrobial and antineoplastic activities of agelasine analogs modified in the purine 2-position. Arch Pharm. 344(1): 50-55. doi: 10.1002/ardp.201000148
Smith PA, Koehler MFT, Girgis HS, Yan D, Chen Y, Chen Y, Crawford JJ, Durk MR, Higuchi RI, Kang J, Murray J, Paraselli P, Park M, Phung W, Quinn JG, Roberts TC, Rouge L, Schwarz JB, Skippington E, Wai J, Xu M, Yu Z, Zhang H, Tan MW, Heise CE. 2018. Optimized arylomycins are a new class of gram-negative antibiotics. Nature 561 : 189–194 https://doi.org/10.1038/s41586-018-0483-6
Tadesse M, Gulliksen B, Strom MB, Styrvold OB, Haug T. 2008. Screening for antibacterial and antifungal activities in marine benthic invertebrates from northern Nowway. Journal of Invertebrtes Pathology 99(3):286-93. doi: 10.1016/j.jip.2008.06.009
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL. 2018. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18 : 318–327. doi: 10.1016/S1473-3099(17)30753-3.
Tommasi R, Brown DG, Walkup GK, Manchester JI, Miller AA. 2015. Eskapeing the labyrinth of antibacterial discovery. Nat. Rev. Drug Dis. 14(8):529-542. doi: 10.1038/nrd4572.
Ventola CL. 2015. The antibiotic resistance crisis: part 1: causes and threats. P&T 40(4): 277-283.
Vik. A Prosyenak A, Vermeersch M, Cos P, Maes L, Gundersen LL. 2009. Screening of Agelasine D and Analogs for Inhibitory Activity against Pathogenic Protozoa; Identification of Hits for Visceral Leishmaniasis and Chagas Disease. Molecules. 14(1): 279-88. doi: 10.3390/molecules14010279.
World Health Organisation. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. https://www.who.int/news-room/detail/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (accessed Oct, 2019).
Yang F, Hamann MT, Zou Y, Zhang MY, Gong XB, Xiao JR, Chen WS, Lin HW. 2012. Antimicrobial metabolites from the Paracel Islands Sponge Agelas mauritiana. J. Nat. Prod. 75 (4) : 774-778. https://doi.org/10.1021/np2009016
Most read articles by the same author(s)
- FITJE LOSUNG, ELVY L. GINTING, BOBBY ABDJUL, MAGIE M. KAPOJOS, WILMAR MAARISIT, FENY MENTANG, DEISKE A. SUMILAT, WALTER BALANSA, REMY E. P. MANGINDAAN, Antimicrobial and FAD synthetases modulating activities of leporins A-C isolated from the sponge-associated fungus Trichoderma sp. , Biodiversitas Journal of Biological Diversity: Vol. 24 No. 12 (2023)